Zacks.com on MSN17h
DexCom Stock Rises Despite Q4 Earnings Miss & Lower Margins
DexCom, Inc. DXCM reported fourth-quarter 2024 adjusted earnings per share (EPS) of 45 cents, which missed the Zacks ...
FDA approves first rapid-acting insulin
According to the FDA, the medication quickly helps to lower mealtime blood sugar spikes to improve control of blood sugar in ...
FDA approves Sanofi biosimilar product for treatment of diabetes
The U.S. Food and Drug Administration approved Merilog as biosimilar to Novolog for the improvement of glycemic control in adults and pediatric ...
Healio6h
FDA approves subcutaneous Merilog for glycemic control in diabetes
The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...
Inc23h
Inc. 5000 2024: Meet the Companies Building the Future
Companies on the 2024 Inc. 5000 are ranked according to percentage revenue growth over the last three years. They generated 874,940 jobs, $317 billion in revenue, and show where the economy is ...